0001209191-17-010023.txt : 20170213
0001209191-17-010023.hdr.sgml : 20170213
20170213163951
ACCESSION NUMBER: 0001209191-17-010023
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161231
FILED AS OF DATE: 20170213
DATE AS OF CHANGE: 20170213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ledda Ralf
CENTRAL INDEX KEY: 0001690024
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 17599856
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2016-12-31
0
0
0
0000742112
INVACARE CORP
IVC
0001690024
Ledda Ralf
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Sen VP/GM-EUR,Mid East&Africa
Common Shares
25200
D
Employee Stock Option (Right to Buy)
Common Shares
14500
14500
D
Includes 24,800 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 1,000 of these restricted stock units vest in full on May 15, 2017 after a three-year "cliff" vesting period; 800 of these restricted stock units vest in 1/2 increments on May 15, 2017 and May 15, 2018; 3,000 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2017; and 20,000 of these restricted stock units vest in full on November 15, 2019 after a three-year "cliff" vesting period.
No transaction is being reported on this line. Reported on a previously filed Form 3.
The reporting person holds previously reported options to buy 14,500 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 22, 2007 and March 18, 2013, at exercise prices between $13.37 to $25.79 per share, will expire between August 22, 2017 and March 18, 2023, and became or will become exercisable between September 30, 2008 and March 31, 2017.
/s/ Ralf Ledda, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated November 10, 2016, on file with the Commission
2017-02-13